Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AAHomecare wants faster DME payments from Medicare

This article was originally published in The Gray Sheet

Executive Summary

A March 2010 report on Medicare contracting reform released recently by the U.S. Government Accountability Office finds that suppliers of durable medical equipment such as home oxygen and power wheelchairs have encountered Medicare payment delays resulting from CMS' attempts to implement several Medicare DME reform initiatives at once. In a May 18 response to the report, Tyler Wilson, president of the American Association for Homecare, writes that "Medicare beneficiaries and those who provide them with vital medical equipment deserve a more efficient administrative process, one that does not create major obstacles for legitimate businesses that are serving some of the most vulnerable people in our society." He calls on Congress and the administration to make fixes

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT028898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel